Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:protein
cytokine interferon alpha |
| gptkbp:administeredBy |
injection
|
| gptkbp:affiliatedWith |
gptkb:type_I_interferons
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:approvedDrugName |
gptkb:Roferon-A
|
| gptkbp:discoveredIn |
1980s
|
| gptkbp:encodedBy |
IFNA2 gene
|
| https://www.w3.org/2000/01/rdf-schema#label |
IFN-alpha-2A
|
| gptkbp:marketedAs |
gptkb:Roche
|
| gptkbp:molecularWeight |
19.2 kDa
|
| gptkbp:producedBy |
recombinant DNA technology
|
| gptkbp:sideEffect |
gptkb:depression
gptkb:anemia fatigue neutropenia flu-like symptoms |
| gptkbp:treatment |
gptkb:hairy_cell_leukemia
gptkb:Kaposi's_sarcoma gptkb:chronic_hepatitis_C leukemia chronic hepatitis B |
| gptkbp:usedAs |
antiviral drug
immunotherapy anticancer agent |
| gptkbp:bfsParent |
gptkb:DB00021
|
| gptkbp:bfsLayer |
7
|